Reinnervate Welcomes its new CEO, Daisuke Usui

Reinnervate Ltd. is pleased to welcome its new Chief Executive Officer (CEO), Mr Daisuke Usui.

Since 2003 Daisuke Usui has been the leader of several business units and companies in healthcare across both mature and emerging markets globally, and he has successfully brought significant leadership and sustainable growth. He has a unique portfolio and diverse experience within sales and marketing, supply chain, strategy development, finance and HR.

Daisuke joined ReproCELL in September 2015 and was appointed CEO of Reinnervate in November 2015.